Home › NDC Lookup › RxCUI directory › RxCUI 1654040

30 ML adenosine 3 MG/ML Injection — RxCUI 1654040

Name: 30 ML adenosine 3 MG/ML Injection (RxCUI 1654040)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1654040 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1654040

Official name30 ML adenosine 3 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asadenosine 90 MG per 30 ML Injection; adenosine 90 MG in 30 mL Injection

FDA products mapped11

Package NDCs mapped18

Reported Medicaid activity (SDUD)1,941 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 30 ML adenosine 3 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 30 ML adenosine 3 MG/ML Injection RxCUI 1654040 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Adenosine 296 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Adenoscan 215025 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Adenosine Injection 1654034 SCDF
- Adenosine Injectable Product 1153467 SCDG
- Adenosine Injection [Adenoscan] 1654036 SBDF
- Adenoscan Injectable Product 1170625 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Adenosine 3 MG/ML 315283 SCDC
- 30 ML adenosine 3 MG/ML Injection [Adenoscan] 1654041 SBD
- Adenosine 3 MG/ML [Adenoscan] 564663 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Adenosine 3 MG/ML SCDC · 315283
Adenosine Injection SCDF · 1654034
Adenosine Injectable Product SCDG · 1153467

Brand-Name Concepts

30 ML adenosine 3 MG/ML Injection [Adenoscan] SBD · 1654041
Adenosine 3 MG/ML [Adenoscan] SBDC · 564663
Adenosine Injection [Adenoscan] SBDF · 1654036
Adenoscan Injectable Product SBDG · 1170625
Adenoscan BN · 215025

📦 FDA Products & Package NDCs

11 products · 18 package NDCs

18 package NDCs map to RxCUI 1654040 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
16714-0556-01	1 VIAL in 1 CARTON (16714-556-01) / 20 mL in 1 VIAL	Adenosine	NorthStar Rx LLC	2022-08-01
16714-0997-01	1 VIAL in 1 CARTON (16714-997-01) / 30 mL in 1 VIAL	Adenosine	NorthStar Rx LLC	2022-08-01
23155-0258-31	1 VIAL in 1 CARTON (23155-258-31) / 20 mL in 1 VIAL	Adenosine	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2021-03-01
23155-0258-32	1 VIAL in 1 CARTON (23155-258-32) / 30 mL in 1 VIAL	Adenosine	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2021-03-01
23155-0258-41	10 VIAL in 1 CARTON (23155-258-41) / 20 mL in 1 VIAL	Adenosine	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2021-03-01
23155-0258-42	10 VIAL in 1 CARTON (23155-258-42) / 30 mL in 1 VIAL	Adenosine	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2021-03-01
55150-0192-01	1 VIAL, SINGLE-DOSE in 1 CARTON (55150-192-01) / 20 mL in 1...	Adenosine	Eugia US LLC	2017-11-02
55150-0192-20	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-192-20) / 20 mL in...	Adenosine	Eugia US LLC	2017-11-02
55150-0193-01	1 VIAL, SINGLE-DOSE in 1 CARTON (55150-193-01) / 30 mL in 1...	Adenosine	Eugia US LLC	2017-11-02
55150-0193-30	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-193-30) / 30 mL in...	Adenosine	Eugia US LLC	2017-11-02
63323-0651-02	10 VIAL, SINGLE-USE in 1 TRAY (63323-651-02) / 2 mL in 1 VI...	Adenosine	Fresenius Kabi USA, LLC	2005-11-23
63323-0651-04	10 VIAL, SINGLE-USE in 1 TRAY (63323-651-04) / 4 mL in 1 VI...	Adenosine	Fresenius Kabi USA, LLC	2005-11-23
63323-0651-20	1 VIAL, SINGLE-DOSE in 1 CARTON (63323-651-20) / 20 mL in 1...	Adenosine	Fresenius Kabi USA, LLC	2017-11-27
63323-0651-30	1 VIAL, SINGLE-DOSE in 1 CARTON (63323-651-30) / 30 mL in 1...	Adenosine	Fresenius Kabi USA, LLC	2017-11-27
67457-0856-20	1 VIAL in 1 CARTON (67457-856-20) / 20 mL in 1 VIAL	Adenosine	Mylan Institutional LLC	2017-08-31
67457-0857-30	1 VIAL in 1 CARTON (67457-857-30) / 30 mL in 1 VIAL	Adenosine	Mylan Institutional LLC	2017-08-31
71288-0207-21	10 VIAL, SINGLE-USE in 1 CARTON (71288-207-21) / 20 mL in 1...	Adenosine	Meitheal Pharmaceuticals Inc.	2025-04-30
71288-0208-30	1 VIAL, SINGLE-USE in 1 CARTON (71288-208-30) / 30 mL in 1...	Adenosine	Meitheal Pharmaceuticals Inc.	2025-04-30

Observed labelers: Eugia US LLC (4) · Fresenius Kabi USA, LLC (4) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (4) · Meitheal Pharmaceuticals Inc. (2) · Mylan Institutional LLC (2) · NorthStar Rx LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0153	Adenosine inj 1mg	12	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.